- Final results of a phase II clinical trial of weekly docetaxel in combination with capecitabine in anthracycline-pretreated metastatic breast cancer. Mackey, J.R., Tonkin, K.S., Koski, S.L., Scarfe, A.G., Smylie, M.G., Joy, A.A., Au, H.J., Bodnar, D.M., Soulieres, D., Smith, S.W. Clin. Breast Cancer (2004)